Skip to main content

Peer Review reports

From: Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trials

Original Submission
25 Dec 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
25 May 2023 Reviewed Reviewer Report
28 May 2023 Reviewed Reviewer Report - Fang Wu
11 Jun 2023 Reviewed Reviewer Report - Jeong Uk Lim
28 Jun 2023 Author responded Author comments - Cheng-Bo Han
Resubmission - Version 3
28 Jun 2023 Submitted Manuscript version 3
29 Jun 2023 Author responded Author comments - Cheng-Bo Han
Resubmission - Version 4
29 Jun 2023 Submitted Manuscript version 4
30 Jun 2023 Author responded Author comments - Cheng-Bo Han
Resubmission - Version 5
30 Jun 2023 Submitted Manuscript version 5
11 Jul 2023 Reviewed Reviewer Report
17 Jul 2023 Reviewed Reviewer Report - Jeong Uk Lim
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
19 Jul 2023 Editorially accepted
1 Aug 2023 Article published 10.1186/s12885-023-11194-6

You can find further information about peer review here.

Back to article page